Blog
RSS FeedPosted by Michael Wonder on 06 Jul 2022
PHARMAC considering funding new medicines for lung cancer
6 July 2022 - PHARMAC is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung ...
Posted by Michael Wonder on 04 Jul 2022
New Zealand Pharmaceutical Schedule - 1 July 2022
5 July 2022 - The July 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 04 Jul 2022
Accuretic users annoyed over contaminated blood pressure medication muddle
4 July 2022 - Confusion continues as Kiwis learn months after the rest of the world that widely used blood ...
Posted by Michael Wonder on 29 Jun 2022
Accuretic supply issue, almost 36,000 New Zealanders taking the blood pressure medicine will need to change treatments
30 June 2022 - PHARMAC has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier ...
Posted by Michael Wonder on 20 Jun 2022
PHARMAC's latest breast cancer drug funding 'way short' - advocate
16 June 2022 - On Wednesday PHARMAC announced $190 million to fund cancer treatments and other medicines. ...
Posted by Michael Wonder on 16 Jun 2022
New PHARMAC funded cancer drugs already 'old and cheap', patient advocate Malcolm Mulholland says
16 June 2022 - New cancer drugs that will now be funded by the Government drug buying agency are already ...
Posted by Michael Wonder on 15 Jun 2022
PHARMAC widens access to safe sex drug after 'overwhelming support'
15 June 2022 - PHARMAC is overhauling its criteria for prescriptions to an effective safe sex drug common to gay men. ...
Posted by Michael Wonder on 15 Jun 2022
PHARMAC announces first round of medicine funding decisions following $191 million pharmaceutical budget increase
15 June 2022 - PHARMAC today announces the first round of changes to medicines funding following its $191 million pharmaceutical ...
Posted by Michael Wonder on 14 Jun 2022
PHARMAC seeks views on access criteria for COVID-19 treatments
14 June 2022 - PHARMAC is seeking feedback on access criteria for two new COVID-19 treatments – tixagevimab with cilgavimab ...
Posted by Michael Wonder on 09 Jun 2022
PHARMAC joins ACT’s call for a medicines strategy
8 June 2022 - “It appears that everyone wants a dedicated Medicines Strategy apart from Andrew Little, who is too ...
Posted by Michael Wonder on 09 Jun 2022
The days of the independent republic of PHARMAC are far from over
9 June 2022 - When he announced the government’s response to the recent independent review of PHARMAC Health Minister Andrew Little ...
Posted by Michael Wonder on 08 Jun 2022
PHARMAC says funding Trikafta would take 'almost all' new money
8 June 2022 - PHARMAC's chairman says funding the cystic fibrosis drug Trikafta would swallow nearly all the new money ...
Posted by Michael Wonder on 02 Jun 2022
Hope for change after PHARMAC independent review
2 June 2022 - A woman who had her bowel removed while she waited for drugs that would probably have ...
Posted by Michael Wonder on 01 Jun 2022
Callous PHARMAC has left too many people in the waiting room of death
2 June 2022 - Early on Wednesday, in Washington DC, our Prime Minister met with the US President, who lauded ...
Posted by Michael Wonder on 01 Jun 2022
Cancer, rare disorder advocates call for more radical change after damning PHARMAC review
2 June 2022 - Radical action is needed urgently to tackle the delays patients face in getting the latest drugs for ...